Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-008725
Filing Date
2016-02-19
Accepted
2016-02-19 15:31:40
Documents
54
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm 10-Q 191015
2 CERTIFICATION nbio_ex311.htm EX-31.1 7715
3 CERTIFICATION nbio_ex312.htm EX-31.2 7725
4 CERTIFICATION nbio_ex321.htm EX-32.1 3244
5 CERTIFICATION nbio_ex322.htm EX-32.2 3531
  Complete submission text file 0001477932-16-008725.txt   1761940

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20151231.xml EX-101.INS 317325
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20151231.xsd EX-101.SCH 30307
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20151231_cal.xml EX-101.CAL 32871
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20151231_def.xml EX-101.DEF 44972
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20151231_lab.xml EX-101.LAB 147910
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20151231_pre.xml EX-101.PRE 127878
Mailing Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 161441684
SIC: 2834 Pharmaceutical Preparations